EP2780011
Samsett meðferð fyrir eggjastokkskrabbamein
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
31.10.2012EP published:
11.4.2018EP application number:
12783804.3
EP translation filed:
7.5.2018Grant published:
15.6.2018EPO information:
European Patent Register
Max expiry date:
30.10.2032Expiry date:
30.10.2020
Title:
COMBINATION THERAPY FOR OVARIAN CANCER
Timeline
Today
31.10.2012EP application
11.4.2018EP Publication
7.5.2018Translation submitted
15.6.2018Registration published
30.10.2020Expires
Owner
Name:
Eli Lilly and CompanyAddress:
Lilly Corporate Center, 46285, Indianapolis, IN, US
Inventor
Name:
CHAN, Edward, MichaelAddress:
Indianapolis, Indiana, US
Name:
PRATT, Susan, ElizabethAddress:
Indianapolis, Indiana, US
Name:
STANCATO, Louis, FrankAddress:
Indianapolis, Indiana, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201161558582 PDate:
11.11.2011Country:
US
Classification
Categories:
A61K 31/437, A61K 31/555, A61K 31/7068, A61P 35/00, A61K 31/282, A61K 33/24
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 12.9.2018
Expires: 30.10.2019
Payer: Örn Þór, slf.
Number: 8
Paid: 12.9.2019
Expires: 30.10.2020
Payer: Örn Þór, slf.